AdTech Vendor · vs · AdTech Vendor
LeadsRx vs LiveRamp
Structured technology and market comparison · 2026
Direct Feature Comparison
LeadsRx · vs · LiveRampAttribution and journey analytics software for enterprise marketers.
Identity and data collaboration software for advertising and measurement.
Analyze all overlapping signals and tech stacks for LeadsRx and LiveRamp
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between LeadsRx and LiveRamp?
When comparing LeadsRx and LiveRamp, both platforms operate within the Customer Data & Clean Room Platform (CDP/DCR), Connected TV (CTV) & OTT, and AdTech Vendor ecosystem. LeadsRx is positioned as Attribution and journey analytics software for enterprise marketers, whereas LiveRamp focuses on Identity and data collaboration software for advertising and measurement. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to LeadsRx and LiveRamp?
When evaluating LeadsRx and LiveRamp, enterprise buyers also consider other platforms in Customer Data & Clean Room Platform (CDP/DCR), Connected TV (CTV) & OTT, and AdTech Vendor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
Market Signals
Recent Market Signals & Activity: LeadsRx vs LiveRamp
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
LeadsRx
Recent Signals
No recent market signals documented for LeadsRx in the current tracking window.
LiveRamp
Recent Signals
- ·The DrumRetail Media Measurement
Retail Media Networks Revive Multi-Touch Attribution
Within a week in September 2026, two major retailers announced new multi-touch attribution (MTA) capabilities for their retail media networks. Albertsons Media Collective launched an incrementality-based MTA built with LiveRamp and piloted by PepsiCo, while Best Buy Ads released its own in-house MTA within My Ads. The author, Kiri Masters, questions the revival given MTA's fall from favor, but analyzes retailer incentives: MTA may serve as a tool to unlock brand budgets, which are larger than performance budgets, by justifying higher CPMs and measuring full-funnel impact. Retailers see demand from shopper marketing teams, but brands and consultants express skepticism about MTA's accuracy, data access, and black-box nature. The article contrasts retailer-owned systems with independent tools like Clerdata, Incremental, Keen Decision Systems, and Circana, and discusses limitations of the Albertsons-LiveRamp partnership, which is grocery-exclusive and excludes Google Search and Amazon.
- Albertsons Media Collective announced Retail Media Incrementality-Based Multi-Touch Attribution on September 17, 2026, built with LiveRamp and piloted by PepsiCo.
- Best Buy Ads confirmed its own multi-touch attribution, built in-house, going live on September 30, 2026, within My Ads.
- Albertsons' MTA connects impression-level exposure across its channels, offsite media, and participating platforms (including Google DV360, Google Ad Manager, Perion) against transaction data.
- ·LiveRamp
Bringing the Power of RampID Globally to Custom Audiences in ChatGPT Ads
LiveRamp announces the global expansion of RampID to custom audiences in ChatGPT Ads, enabling marketers to leverage identity resolution for AI-driven advertising.
- ·SEC APIfinancials
8-K Financial Filing Analysis for LiveRamp (2026-08-20)
On August 17, 2026, LiveRamp Holdings, Inc. formally reduced the size of its Board of Directors from seven to six members following the previously disclosed resignation of director Kristi Argyilan on July 17, 2026. To eliminate the resulting vacancy and ensure balanced class representation across its staggered board, the Board redesignated director Vivian Chow from the class with terms expiring at the 2029 annual meeting to the class expiring at the 2028 annual meeting. This administrative governance adjustment maintains statutory board parity without creating operational disruptions.
- LiveRamp reduced its Board size from 7 to 6 directors on August 17, 2026, eliminating the vacancy from Kristi Argyilan's July 17, 2026 resignation.
- Director Vivian Chow was redesignated from the class expiring at the 2029 annual meeting to the class expiring at the 2028 annual meeting to rebalance board classes.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners LeadsRx and LiveRamp share across the market ecosystem.